Thrombosis News and Research

Latest Thrombosis News and Research

Combination of microfluidic technology and blood flow research may help understand cardiovascular diseases

Announcing a new publication for BIO Integration journal. In this article the authors Meng Zhang, Wu Zhang, Zihuang Wang and Weiqian Chen from Sun Yat-Sen University, Guangzhou, China, Harvard University, Cambridge, MA, USA and Guangzhou University, Guangzhou, China review viscoelastic flow mixing in microfluidics.

3 Dec 2020

Innovative, integrated approaches can improve cardiovascular health, shows study

For cardiovascular health to improve in the general population, healthcare systems will need to collect and assess treatment data, establish collaboration between researchers and healthcare professionals, and evolve patient care in real-time based on those data.

3 Dec 2020

Autoantigen may help prevent and treat cardiovascular disease

Mitochondrial protein ALDH4A1 has been identified as an autoantigen implicated in atherosclerosis.

2 Dec 2020

Asymptomatic patients have higher SARS-CoV-2 viral loads than symptomatic patients, study says

Now, a surprising new study shows that asymptomatic COVID-19 patients have greater viral loads than those with symptoms.

29 Nov 2020

Aprotinin inhibits SARS-CoV-2 entry and replication in cells cultures

Researchers at the University of Kent in the UK and the Hannover Medical School and Goethe University in Germany have observed that the protease inhibitor aprotinin can inhibit viral replication by preventing SARS-CoV-2 entry into host cells.

24 Nov 2020

$Z-drugs can increase risk of falls, fractures, and stroke in dementia patients$

Z-drugs can increase risk of falls, fractures, and stroke in dementia patients

Strong sleeping pills known as 'Z-drugs' are linked with an increased risk of falls, fractures and stroke among people with dementia - according to research from the University of East Anglia.

24 Nov 2020

Thromboembolism in COVID-19 patients associated with higher risk of mortality

While respiratory issues continue to be the most common symptom of a COVID-19 infection, new research indicates the disease could also be associated with hypercoagulability, or increased tendency of the blood to clot.

23 Nov 2020

International trialists receive prestigious award for research on low-dose aspirin

The international trialists Professors Lars Wallentin, Jan van Gijn, Bo Norrving and Tom Meade were recognized for their work on low-dose aspirin, with the presentation of the International Aspirin Foundation Senior Science Award.

22 Nov 2020

Study highlights the role of genetic testing in evaluation of in-stent thrombosis

In a new publication from Cardiovascular Innovations and Applications, Nathan Burke, Tawanna Charlton, Hussam Hawamdeh, and Ki Park from the University of Florida College of Medicine, Gainesville.

20 Nov 2020

Somatic mutation may act as a natural gene therapy in patients with rare autosomal disease

Researchers affiliated with the Center for Cell-Based Therapy in Ribeirão Preto, Brazil, have identified for the first time a non-hereditary mutation in blood cells from a patient with GATA2 deficiency, a rare autosomal disease caused by inherited mutations in the gene that encodes GATA-binding protein 2 (GATA2).

17 Nov 2020

ECG abnormalities can predict COVID-19 mortality

A team of scientists from New York University Langone Medical Center, USA, has revealed that the clinical severity of hospitalized patients with coronavirus disease 2019 (COVID-19) can be predicted by analyzing the level of troponin elevation and electrocardiographic (ECG) abnormalities. The study is currently available on the medRxiv preprint server.

17 Nov 2020

Study identifies new factor that offers potential strategy for treating obesity

Obesity is a serious global health problem and a risk factor for diseases such as type II diabetes, heart disease and fatty liver disease.

17 Nov 2020

Study: High-dose blood thinners have no additional benefit in COVID-19 patients

While COVID-19 infected patients should be treated with standard anticoagulation therapies, such as blood thinning medication, a new study by researchers at the George Washington University (GW) shows that anticoagulating patients at higher doses, without traditional medical indications to do so, may be ineffective and even harmful.

16 Nov 2020

Baricitinib drug can reduce mortality in patients with moderate to severe COVID-19

The rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to severe COVID-19, according to translational research by an international team coordinated by researchers from Karolinska Institutet in Sweden.

16 Nov 2020

Drugs targeting neutrophils could reduce ARDS in severe COVID-19

Scientists in Taiwan recently published a report on their use of anti-neutrophil strategies to treat acute respiratory distress syndrome (ARDS) – a life-threatening condition that can arise in critical COVID-19 cases – in the journal Frontiers in Pediatrics.

15 Nov 2020

Critically ill COVID-19 patients experience novel platelet-activating immune complexes, study finds

Canadian researchers from McMaster University, Ontario, have pinpointed platelet activating immune complexes in coagulation disorders associated with coronavirus disease 2019 (COVID-19), the condition caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

10 Nov 2020

HSS presents research related to rheumatology and orthopedic surgery at 2020 ACR annual meeting

At this year's American College of Rheumatology virtual meeting, Hospital for Special Surgery (HSS) presented exciting research related to rheumatology and orthopedic surgery.

10 Nov 2020

ACE2 and TMPRSS2 not the only virus-receptors to mediate SARS-CoV-2 entry

However, a recent study published on the preprint server bioRxiv in November 2020 uncovers the major role played by the N-terminal domain of the SARS-CoV-2 virus in host infection. This could be of great use in measuring the usefulness of antibodies used in convalescent plasma therapy for COVID-19.

9 Nov 2020

Reducing the airborne transmission risk for SARS-CoV-2

Rapid Reviews: COVID-19 (RR:C19), an open-access overlay journal published by the MIT Press that accelerates peer review of COVID-19-related research preprints, is currently soliciting reviews of the following COVID-19 preprints.

6 Nov 2020

Persistent and extensive lung damage seen in COVID-19 patients

A team of researchers at the University of Trieste in Italy aimed to determine the extent and the causes of lung damage from COVID-19 to better understand the pathological correlates of the disease.

5 Nov 2020

Thrombosis News and Research

Latest Thrombosis News and Research

Combination of microfluidic technology and blood flow research may help understand cardiovascular diseases

Innovative, integrated approaches can improve cardiovascular health, shows study

Autoantigen may help prevent and treat cardiovascular disease

Asymptomatic patients have higher SARS-CoV-2 viral loads than symptomatic patients, study says

Aprotinin inhibits SARS-CoV-2 entry and replication in cells cultures

Z-drugs can increase risk of falls, fractures, and stroke in dementia patients

Thromboembolism in COVID-19 patients associated with higher risk of mortality

International trialists receive prestigious award for research on low-dose aspirin

Study highlights the role of genetic testing in evaluation of in-stent thrombosis

Somatic mutation may act as a natural gene therapy in patients with rare autosomal disease

ECG abnormalities can predict COVID-19 mortality

Study identifies new factor that offers potential strategy for treating obesity

Study: High-dose blood thinners have no additional benefit in COVID-19 patients

Baricitinib drug can reduce mortality in patients with moderate to severe COVID-19

Drugs targeting neutrophils could reduce ARDS in severe COVID-19

Critically ill COVID-19 patients experience novel platelet-activating immune complexes, study finds

HSS presents research related to rheumatology and orthopedic surgery at 2020 ACR annual meeting

ACE2 and TMPRSS2 not the only virus-receptors to mediate SARS-CoV-2 entry

Reducing the airborne transmission risk for SARS-CoV-2

Persistent and extensive lung damage seen in COVID-19 patients

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Thrombosis News and Research

Latest Thrombosis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in